Publications
Print PDF
FDA Beats Ranbaxy Suit Despite 'Serious' Approval Errors
March 11, 2015
Jeff Overley
Law360

Axinn Partner Chad Landmon was quoted in the Law360 article, "FDA Beats Ranbaxy Suit Despite 'Serious' Approval Errors."

Click here to access the article. A Law360 subscription is required.

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.